HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study
about
Helminthic infections rates and malaria in HIV-infected pregnant women on anti-retroviral therapy in Rwanda.Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsPresence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected PopulationMalaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies.Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Altered Plasmodium falciparum Sensitivity to the Antiretroviral Protease Inhibitor Lopinavir Associated with Polymorphisms in pfmdr1.Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.Buy one, get one free? Benefits of certain antiretrovirals against malaria.
P2860
Q21562241-7224281A-D048-4D37-9AF9-494D68568B33Q35286119-E523F65A-5AD8-4553-9481-2FF353489438Q35656242-B546B512-28EA-4B49-A8AA-76F58610B5B7Q36218701-A6678661-8F09-4511-AA33-7DF98C8557BEQ36743880-ECDF94EE-A6AA-421D-9DF1-5E22C002C126Q37096787-710BD60E-1A8C-47CB-8EC8-065080DC9548Q37538658-8BA07C8C-E1BD-439B-9E34-7694EB431928Q37613241-F1C16E94-2205-4043-9A2D-D3AB0C70EE73Q40529360-A8024644-4F35-474D-825E-4B696BE051BC
P2860
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@ast
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@en
type
label
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@ast
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@en
prefLabel
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@ast
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@en
P2093
P2860
P50
P356
P1476
HIV-1 protease inhibitors and ...... nical Trials Group A5208 study
@en
P2093
Abraham Siika
Charles Poole
Doug Shaffer
Elizabeth Stringer
Frederick K Sawe
James S McCarthy
Judith S Currier
Kimberly A Porter
Michael D Hughes
Mina Hosseinipour
P2860
P304
P356
10.1128/AAC.05322-11
P407
P577
2011-11-28T00:00:00Z